PatientsVille.com Logo

Cancidas Side Effects

PatientsVille

Common Cancidas Side Effects


The most commonly reported Cancidas side effects (click to view or check a box to report):

Death (62)
Multi-organ Failure (55)
Septic Shock (46)
Bronchopulmonary Aspergillosis (44)
Respiratory Failure (40)
Sepsis (38)
Aspergillosis (33)
Systemic Candida (31)
Graft Versus Host Disease (27)
Hepatic Failure (25)
Blood Bilirubin Increased (22)
Pneumonia (21)
Renal Failure Acute (21)
Pyrexia (21)
Alanine Aminotransferase Increased (20)
Condition Aggravated (19)
Aspartate Aminotransferase Increased (18)
Acute Respiratory Distress Syndrome (18)
Acute Myeloid Leukaemia (18)
Dyspnoea (18)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Cancidas Side Effects Reported to FDA



Cancidas Side Effect Report#9998340
Renal Failure, Hemiplegia, Endotracheal Intubation, Haemorrhage Intracranial, Intracranial Pressure Increased, Renal Tubular Necrosis
This is a report of a 64-year-old male patient (weight: NA) from ZA, suffering from the following health symptoms/conditions: candida infection, who was treated with Cancidas 50mg (dosage: Unk, start time: NS), combined with:
  • Epilim (800 G, Q12h)
and developed a serious reaction and side effect(s): Renal Failure, Hemiplegia, Endotracheal Intubation, Haemorrhage Intracranial, Intracranial Pressure Increased, Renal Tubular Necrosis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cancidas 50mg treatment in male patients, resulting in Renal Failure side effect.
Cancidas Side Effect Report#9991389
Venoocclusive Disease
This report suggests a potential Cancidas For Intravenous Drip Infusion 50mg Venoocclusive Disease side effect(s) that can have serious consequences. A male patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: febrile neutropenia and used Cancidas For Intravenous Drip Infusion 50mg (dosage: 50 Mg, Qd) starting
Sep 19, 2013. After starting Cancidas For Intravenous Drip Infusion 50mg the patient began experiencing various side effects, including: Venoocclusive DiseaseAdditional drugs used concurrently:
  • Cancidas For Intravenous Drip Infusion 70mg (70 Mg, Qd)
  • Funguard (50 Mg, Qd)
  • Meropen (1 G, Tid)
  • Finibax (1 G, Tid)
  • Teicoplanin (800 Mg, Qd)
  • Sandimmun (300 Mg, Qd)
  • Gran (450 Microgram, Qd)
  • Gaster (famotidine) (20 Mg, Qd)
The patient was hospitalized. Although Cancidas For Intravenous Drip Infusion 50mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Venoocclusive Disease, may still occur.
Cancidas Side Effect Report#9989234
Adult T-cell Lymphoma/leukaemia, Sepsis, Hypokalaemia
This Adult T-cell Lymphoma/leukaemia problem was reported by a consumer or non-health professional from JP. A 75-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: febrile neutropenia. On
Jan 23, 2014 this consumer started treatment with Cancidas For Intravenous Drip Infusion 70mg (dosage: 70 Mg, Qd). The following drugs were being taken at the same time:
  • Cancidas For Intravenous Drip Infusion 50mg (50 Mg, Qd)
  • Fluconazole
  • Metgluco (250 Mg, Bid)
  • Tamsulosin Hydrochloride (0.2 Mg, Qd)
  • Magmitt (330 Mg, Tid)
  • Nexium (20 Mg, Qd)
  • Daiphen (1 G, Qd)
  • Iscotin (300 Mg, Qd)
When using Cancidas For Intravenous Drip Infusion 70mg, the patient experienced the following unwanted symptoms/side effects: Adult T-cell Lymphoma/leukaemia, Sepsis, HypokalaemiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Adult T-cell Lymphoma/leukaemia, may become evident only after a product is in use by the general population.
Cancidas Side Effect Report#9924111
Pneumonia, Renal Disorder, Amylase Increased
This Pneumonia side effect was reported by a consumer or non-health professional from JP. A 82-year-old male patient (weight:NA) experienced the following symptoms/conditions: interstitial lung disease.The patient was prescribed Cancidas For Intravenous Drip Infusion 50mg (drug dosage: 50 Mg, Qd), which was initiated on
Oct 15, 2013. Concurrently used drugs:
  • Cancidas For Intravenous Drip Infusion 70mg (70 Mg, Qd)
  • Meropen (1 G, Bid)
  • Prednisolone (30 Mg, Bid)
  • Sol Melcort (1 G, Qd)
  • Vancomycin (1 G, Qd)
  • Baktar (3 Df, Tid)
.After starting to take Cancidas For Intravenous Drip Infusion 50mg the consumer reported adverse symptoms, such as: Pneumonia, Renal Disorder, Amylase IncreasedThese side effects may potentially be related to Cancidas For Intravenous Drip Infusion 50mg.
Cancidas Side Effect Report#9923575
Acute Myeloid Leukaemia, Febrile Neutropenia, Cardiac Failure, Pneumonia
This is a report of a 79-year-old female patient (weight: NA) from JP, suffering from the following health symptoms/conditions: febrile neutropenia, who was treated with Cancidas For Intravenous Drip Infusion 50mg (dosage: 50 Mg, Qd, start time:
Apr 14, 2013), combined with:
  • Cancidas For Intravenous Drip Infusion 70mg (70 Mg, Qd)
  • Itraconazole
  • Lasix (furosemide) (20 Mg, Qd)
  • Aldactone A (25 Mg, Qd)
  • Evista (60 Mg, Qd)
  • Hypen (200 Mg, Bid)
  • Gaslon (2 Df, Qd)
  • Crestor (2.5 Mg, Qd)
and developed a serious reaction and side effect(s): Acute Myeloid Leukaemia, Febrile Neutropenia, Cardiac Failure, Pneumonia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cancidas For Intravenous Drip Infusion 50mg treatment in female patients, resulting in Acute Myeloid Leukaemia side effect.
Cancidas Side Effect Report#9922050
Dysphagia, Tongue Oedema
This report suggests a potential Cancidas Dysphagia side effect(s) that can have serious consequences. A 48-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: pneumonia influenzal and used Cancidas (dosage: 1 Df, Qd) starting
Jan 29, 2014. After starting Cancidas the patient began experiencing various side effects, including: Dysphagia, Tongue OedemaAdditional drugs used concurrently:
  • Cefotaxime Sodium (1 G, Tid)
  • Triatec (ramipril) (2 Df, Qd)
Although Cancidas demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dysphagia, may still occur.
Cancidas Side Effect Report#9893244
Interstitial Lung Disease, Constipation
This Interstitial Lung Disease problem was reported by a consumer or non-health professional from JP. A 68-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: bronchopulmonary aspergillosis. On
Dec 25, 2013 this consumer started treatment with Cancidas For Intravenous Drip Infusion 50mg (dosage: 50 Mg, Qd). The following drugs were being taken at the same time:
  • Cancidas For Intravenous Drip Infusion 70mg (70 Mg, Once)
  • Salipara-codeine (6 Ml, Tid)
  • Azilva (20 Mg, Qd)
  • Atovaquone (1 Ml, Bid)
  • Allopurinol (100 Mg, Bid)
  • Geninax (200 Mg, Qd)
  • Asverin (20 Mg, Tid)
  • Predonine (60 Mg, Qd)
When using Cancidas For Intravenous Drip Infusion 50mg, the patient experienced the following unwanted symptoms/side effects: Interstitial Lung Disease, ConstipationAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Interstitial Lung Disease, may become evident only after a product is in use by the general population.
Cancidas Side Effect Report#9880297
Agranulocytosis, Leukopenia, Neutropenia, Rash Maculo-papular
This Agranulocytosis side effect was reported by a health professional from FR. A 60-year-old male patient (weight:NA) experienced the following symptoms/conditions: superinfection fungal.The patient was prescribed Cancidas (drug dosage: Unk), which was initiated on
Dec 14, 2012. Concurrently used drugs:
  • Atrovent
  • Bricanyl
.After starting to take Cancidas the consumer reported adverse symptoms, such as: Agranulocytosis, Leukopenia, Neutropenia, Rash Maculo-papularThese side effects may potentially be related to Cancidas. The patient was hospitalized.
Cancidas Side Effect Report#9879541
Renal Failure Chronic, Pneumonia
This is a report of a male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: pneumonia, who was treated with Cancidas For Intravenous Drip Infusion 70mg (dosage: 70 Mg, Once, start time:
Dec 13, 2013), combined with: NA. and developed a serious reaction and side effect(s): Renal Failure Chronic, Pneumonia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cancidas For Intravenous Drip Infusion 70mg treatment in male patients, resulting in Renal Failure Chronic side effect.
Cancidas Side Effect Report#9870104
Agranulocytosis
This report suggests a potential Cancidas Agranulocytosis side effect(s) that can have serious consequences. A 53-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: pneumonia,endocarditis,sepsis and used Cancidas (dosage: Unk) starting
Dec 05, 2013. After starting Cancidas the patient began experiencing various side effects, including: AgranulocytosisAdditional drugs used concurrently:
  • Orbenine (Unk)
  • Dalacine (Unk)
  • Rifadin (Unk)
  • Inexium (Unk)
Although Cancidas demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Agranulocytosis, may still occur.
Cancidas Side Effect Report#9869206
Septic Shock, Infarction, Incorrect Dosage Administered
This Septic Shock problem was reported by a physician from FR. A 52-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: systemic candida. On
Feb 17, 2013 this consumer started treatment with Cancidas (dosage: 50 Mg, Qd). The following drugs were being taken at the same time: NA. When using Cancidas, the patient experienced the following unwanted symptoms/side effects: Septic Shock, Infarction, Incorrect Dosage AdministeredAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Septic Shock, may become evident only after a product is in use by the general population.
Cancidas Side Effect Report#9868317
Infection
This Infection side effect was reported by a pharmacist from GB. A 73-year-old male patient (weight:NA) experienced the following symptoms/conditions: infection.The patient was prescribed Cancidas (drug dosage: Od), which was initiated on NS. Concurrently used drugs: NA..After starting to take Cancidas the consumer reported adverse symptoms, such as: InfectionThese side effects may potentially be related to Cancidas. The patient was hospitalized.
Cancidas Side Effect Report#9858242
Cholestasis, Gamma-glutamyltransferase Increased, Transaminases Increased
This is a report of a 59-year-old male patient (weight: NA) from FR, suffering from the following health symptoms/conditions: respiratory moniliasis, who was treated with Cancidas (dosage: 70 Mg, Once, start time:
Aug 02, 2013), combined with: NA. and developed a serious reaction and side effect(s): Cholestasis, Gamma-glutamyltransferase Increased, Transaminases Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cancidas treatment in male patients, resulting in Cholestasis side effect. The patient was hospitalized.
Cancidas Side Effect Report#9826148
Off Label Use
This report suggests a potential Cancidas Death side effect(s) that can have serious consequences. A 60-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: aspergillus infection and used Cancidas (dosage: 70 Mg, Qd) starting
Jan 12, 2013. After starting Cancidas the patient began experiencing various side effects, including: Off Label UseAdditional drugs used concurrently: NA. Although Cancidas demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.
Cancidas Side Effect Report#9809333
Eosinophilia
This Eosinophilia problem was reported by a pharmacist from US. A 69-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: fungal infection. On 201312 this consumer started treatment with Cancidas (dosage: 50 Mg, Once Daily). The following drugs were being taken at the same time: NA. When using Cancidas, the patient experienced the following unwanted symptoms/side effects: EosinophiliaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Eosinophilia, may become evident only after a product is in use by the general population.
Cancidas Side Effect Report#9779409
Neutropenic Sepsis, Pneumonia Fungal
This Neutropenic Sepsis side effect was reported by a physician from DE. A 75-year-old male patient (weight:NA) experienced the following symptoms/conditions: pneumonia fungal.The patient was prescribed Cancidas (drug dosage: Unk), which was initiated on
Apr 04, 2010. Concurrently used drugs:
  • Moxifloxacin Hydrochloride
  • Piperacillin Sodium (+) Sulbactam Sodium
  • Metoprolol
  • Amiodarone
  • Morphine
.After starting to take Cancidas the consumer reported adverse symptoms, such as: Neutropenic Sepsis, Pneumonia FungalThese side effects may potentially be related to Cancidas.
Cancidas Side Effect Report#9778561
Acute Lymphocytic Leukaemia, Sepsis, Cerebral Fungal Infection, Multi-organ Failure
This is a report of a 37-year-old male patient (weight: NA) from DE, suffering from the following health symptoms/conditions: febrile neutropenia, who was treated with Cancidas (dosage: 70 Mg, Qd, start time:
Oct 17, 2010), combined with: NA. and developed a serious reaction and side effect(s): Acute Lymphocytic Leukaemia, Sepsis, Cerebral Fungal Infection, Multi-organ Failure after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cancidas treatment in male patients, resulting in Acute Lymphocytic Leukaemia side effect.
Cancidas Side Effect Report#9776234
Respiratory Failure, Atypical Pneumonia
This report suggests a potential Cancidas Respiratory Failure side effect(s) that can have serious consequences. A 21-year-old female patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: atypical pneumonia and used Cancidas (dosage: NA) starting
Aug 26, 2009. After starting Cancidas the patient began experiencing various side effects, including: Respiratory Failure, Atypical PneumoniaAdditional drugs used concurrently: NA. Although Cancidas demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Respiratory Failure, may still occur.
Cancidas Side Effect Report#9771810
Condition Aggravated
This Condition Aggravated problem was reported by a physician from DE. A 80-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: pyrexia,evidence based treatment. On
Jun 12, 2008 this consumer started treatment with Cancidas (dosage: Unk). The following drugs were being taken at the same time: NA. When using Cancidas, the patient experienced the following unwanted symptoms/side effects: Condition AggravatedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Condition Aggravated, may become evident only after a product is in use by the general population.
Cancidas Side Effect Report#9768852
Hepatitis Fulminant, Acute Hepatic Failure, Decreased Appetite, Jaundice, Hepatic Enzyme Increased, Blood Bilirubin Increased
This Hepatitis Fulminant side effect was reported by a physician from IN. A 56-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Cancidas (drug dosage: Unk), which was initiated on 201010. Concurrently used drugs:
  • Zienam (Unk)
  • Zorem (Unk Unk, Bid)
.After starting to take Cancidas the consumer reported adverse symptoms, such as: Hepatitis Fulminant, Acute Hepatic Failure, Decreased Appetite, Jaundice, Hepatic Enzyme Increased, Blood Bilirubin IncreasedThese side effects may potentially be related to Cancidas. The patient was hospitalized.
Cancidas Side Effect Report#9759505
Hypernatraemia, Renal Impairment, Hepatic Function Abnormal
This is a report of a 85-year-old male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: systemic candida, who was treated with Cancidas For Intravenous Drip Infusion 50mg (dosage: 50 Mg, Qd, start time:
Oct 10, 2013), combined with:
  • Cancidas For Intravenous Drip Infusion 70mg (70 Mg, Qd)
  • Lyrica (25 Mg, Tid)
  • Lyrica (25 Mg, Qd)
  • Zosyn (2.5 G, Tid)
  • Digosin (125 Microgram, Qd)
  • Vasolan (2.5 Mg, Qd)
  • Heparin Sodium (1 Thousand-million Unit, Qd)
  • Depakene (300 Mg, Tid)
and developed a serious reaction and side effect(s): Hypernatraemia, Renal Impairment, Hepatic Function Abnormal after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cancidas For Intravenous Drip Infusion 50mg treatment in male patients, resulting in Hypernatraemia side effect. The patient was hospitalized.
Cancidas Side Effect Report#9742379
Pulmonary Alveolar Haemorrhage
This report suggests a potential Cancidas For Intravenous Drip Infusion 50mg Pulmonary Alveolar Haemorrhage side effect(s) that can have serious consequences. A 75-year-old female patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: bronchopulmonary aspergillosis and used Cancidas For Intravenous Drip Infusion 50mg (dosage: 50 Mg, Qd) starting
Dec 01, 2013. After starting Cancidas For Intravenous Drip Infusion 50mg the patient began experiencing various side effects, including: Pulmonary Alveolar HaemorrhageAdditional drugs used concurrently:
  • Cancidas For Intravenous Drip Infusion 70mg (70 Mg, Qd)
  • Sol Melcort (500 Mg, Qd)
  • Predonine (30 Mg, Qd)
  • Endoxan (225 Mg, Qd)
Although Cancidas For Intravenous Drip Infusion 50mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pulmonary Alveolar Haemorrhage, may still occur.
Cancidas Side Effect Report#9736742
Renal Failure
This Renal Failure problem was reported by a health professional from FR. A 75-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: bronchopulmonary aspergillosis. On
Nov 06, 2013 this consumer started treatment with Cancidas (dosage: 50 Mg, Qd). The following drugs were being taken at the same time:
  • Zelitrex (2 Df, Tid)
  • Vfend (450 Mg, Qd)
  • Cardensiel (Unk)
  • Hyperium (Unk)
  • Amlor (Unk)
  • Atarax (alprazolam) (Unk)
  • Inexium (Unk)
  • Cortancyl (Unk)
When using Cancidas, the patient experienced the following unwanted symptoms/side effects: Renal FailureAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Renal Failure, may become evident only after a product is in use by the general population.
Cancidas Side Effect Report#9733879
Viith Nerve Paralysis
This Viith Nerve Paralysis side effect was reported by a health professional from FR. A 59-year-old male patient (weight:NA) experienced the following symptoms/conditions: bronchopulmonary aspergillosis.The patient was prescribed Cancidas (drug dosage: 50 Mg, Qd), which was initiated on
Sep 05, 2013. Concurrently used drugs:
  • Vfend (200 Mg, Bid)
  • Revolade (25 Mg, Tid)
  • Valacyclovir Hydrochloride (500 Mg, Qd)
.After starting to take Cancidas the consumer reported adverse symptoms, such as: Viith Nerve ParalysisThese side effects may potentially be related to Cancidas. The patient was hospitalized.
Cancidas Side Effect Report#9725385
Renal Failure, Hepatic Failure, Respiratory Disorder, Coagulation Test Abnormal
This is a report of a 34-year-old male patient (weight: NA) from ES, suffering from the following health symptoms/conditions: febrile neutropenia, who was treated with Cancidas (dosage: Unk, Daily, start time:
Nov 11, 2013), combined with: NA. and developed a serious reaction and side effect(s): Renal Failure, Hepatic Failure, Respiratory Disorder, Coagulation Test Abnormal after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cancidas treatment in male patients, resulting in Renal Failure side effect. The patient was hospitalized.


1 of 32 


The appearance of Cancidas on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Cancidas Side Effects for Women?

Women Side EffectsReports
Septic Shock 25
Death 22
Hepatic Failure 18
Multi-organ Failure 17
Sepsis 17
Respiratory Failure 15
Convulsion 14
Hepatic Necrosis 12
Systemic Candida 12
Jaundice 11

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Cancidas reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Cancidas Side Effects

    Did You Have a Cancidas Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Cancidas for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Cancidas Safety Alerts, Active Ingredients, Usage Information

    NDC0006-3822
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameCANCIDAS
    NameCASPOFUNGIN ACETATE
    Dosage FormINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    RouteINTRAVENOUS
    On market since20010126
    LabelerMerck Sharp & Dohme Corp.
    Active Ingredient(s)CASPOFUNGIN ACETATE
    Strength(s)5
    Unit(s)mg/mL
    Pharma ClassEchinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]

    Cancidas Dosage, Warnings, Usage.

    Side Effects reported to FDA: 792

    Cancidas safety alerts: No

    Reported deaths: 476

    Reported hospitalizations: 376

    Latest Cancidas clinical trials

    Cancidas Reviews

    No reviews, be a first to report a side effect via side effect reporting form